CAS: 33755-46-3 - 9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17-valerate
Formel:C27H37FO6
InChl:InChI=1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3/t16-,19+,20+,21+,24+,25+,26+,27+/m1/s1
InChI Key:InChIKey=SNHRLVCMMWUAJD-OMPPIWKSSA-N
SMILES:O=C1C=CC2(C(=C1)CCC3C4CC(C)C(OC(=O)CCCC)(C(=O)CO)C4(C)CC(O)C32F)C
- Synonyme:
- (11Beta,16Alpha)-9-Fluoro-11,21-Dihydroxy-16-Methyl-3,20-Dioxopregna-1,4-Dien-17-Yl Pentanoate
- (11β,16α)-9-Fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione
- 251-669-2
- Dexamethasone 17-valerate
- Dexamethasone valerate
- Dv 17
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11β,16α)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11β,17,21-trihydroxy-16α-methyl-, 17-valerate
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Betamethasone Valerate EP Impurity C REF: 4Z-B-065027CAS: 33755-46-3 | - - - | Nachfragen | Di 07 Jan 25 | |
Dexamethasone Valerate REF: TR-D298870CAS: 33755-46-3 | - - - | 237,00 €~1.898,00 € | Mi 15 Jan 25 | |
Dexamethasone Valerate-d9 REF: TR-D298872CAS: 33755-46-3 | - - - | 3.575,00 € | Di 18 Feb 25 | |
Dexamethasone valerate REF: 3D-FD102565CAS: 33755-46-3 | Min. 95% | - - - | Ausgelaufenes produkt |
Betamethasone Valerate EP Impurity C
Ref: 4Z-B-065027
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
Dexamethasone Valerate
Ref: TR-D298870
10mg | 394,00 € | ||
100mg | 1.898,00 € | ||
2500µg | 237,00 € |
Dexamethasone Valerate-d9
Kontrolliertes ProduktRef: TR-D298872
25mg | 3.575,00 € |
Dexamethasone valerate
Kontrolliertes ProduktRef: 3D-FD102565
1mg | Ausgelaufen | Anforderung von Informationen | |
2mg | Ausgelaufen | Anforderung von Informationen | |
5mg | Ausgelaufen | Anforderung von Informationen | |
250µg | Ausgelaufen | Anforderung von Informationen | |
500µg | Ausgelaufen | Anforderung von Informationen |